
Strategy development – Setting priorities for PHA UK
Pulmonary Hypertension (PH) is an incurable, serious condition, with a major lifelong impact on patients. Diagnosis and treatment is complex, and requires high-cost drug therapies,
Pulmonary Hypertension (PH) is an incurable, serious condition, with a major lifelong impact on patients. Diagnosis and treatment is complex, and requires high-cost drug therapies,
Following its launch, Patient Focused Medicine Development (PFMD), needed rapid support to establish and build its patient engagement framework. It sought a credible partner that
What kind of information would help patients be better at taking their medicines?
Monmouth undertook a major review of how NHS Digital (the then HSCIC) involves patients in its work. Using our ‘Maturity Model’ we benchmarked how NHS
“Monmouth really helped us communicate directly with patients and the public on a complex and technical subject. By hearing what matters most to patients we
“We appreciated PIF mapping out and analysing patient/public voice remuneration rates and policies across the system. The information you collated on behalf of the system
Individual Participation is about giving patients, carers and others who use health and care services information and support to express their preferences for care
Monmouth launched two rapid self-diagnostics, enabling healthcare organisations to assess how mature their approaches to Individual Participation and Patient and Public Engagement (PPE) are.
As part of its work on medicines optimisation NHS England has prepared a report, co-produced with Monmouth Partners, to present the outcomes and supporting evidence from a one-day patient engagement workshop.
Monmouth’s briefing provides a guide to the landscape and some practical insights into how NHS leaders can leverage evidence-based Patient and Public Engagement (PPE) techniques to help unlock the power of engaged patients.
Pulmonary Hypertension (PH) is an incurable, serious condition, with a major lifelong impact on patients. Diagnosis and treatment is complex, and requires high-cost drug therapies,
Following its launch, Patient Focused Medicine Development (PFMD), needed rapid support to establish and build its patient engagement framework. It sought a credible partner that
What kind of information would help patients be better at taking their medicines?
Monmouth undertook a major review of how NHS Digital (the then HSCIC) involves patients in its work. Using our ‘Maturity Model’ we benchmarked how NHS
“Monmouth really helped us communicate directly with patients and the public on a complex and technical subject. By hearing what matters most to patients we
“We appreciated PIF mapping out and analysing patient/public voice remuneration rates and policies across the system. The information you collated on behalf of the system
Individual Participation is about giving patients, carers and others who use health and care services information and support to express their preferences for care
Monmouth launched two rapid self-diagnostics, enabling healthcare organisations to assess how mature their approaches to Individual Participation and Patient and Public Engagement (PPE) are.
As part of its work on medicines optimisation NHS England has prepared a report, co-produced with Monmouth Partners, to present the outcomes and supporting evidence from a one-day patient engagement workshop.
Monmouth’s briefing provides a guide to the landscape and some practical insights into how NHS leaders can leverage evidence-based Patient and Public Engagement (PPE) techniques to help unlock the power of engaged patients.